MEGAN BOYCE: Open Payments
NPI 1811442478 · SEWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 38 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,013
Food & beverage: $838Education: $176
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $235 |
| ABBVIE INC. | 8 | $225 |
| LEO Pharma Inc. | 10 | $169 |
| Regeneron Healthcare Solutions, Inc. | 2 | $109 |
| Incyte Corporation | 4 | $76 |
| Amgen Inc. | 4 | $75 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
| UCB, Inc. | 2 | $35 |
| GENZYME CORPORATION | 1 | $19 |
| Almirall LLC | 1 | $18 |
Products named: TREMFYA, SKYRIZI, ADBRY, DUPIXENT, OPZELURA, OTEZLA, Bimzelx, ANZUPGO.
Industry payments across NJ — which companies pay providers there.
